Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulimorelin in Enteral Feeding Intolerance
NCT02784392Phase 2Completed
- Sponsor
- Lyric Pharmaceuticals
- Start
- Oct 2016
- Primary completion
- Mar 2018
- Countries
- 3
01
Overview
A Phase 2 trial of ulimorelin in enteral feeding intolerance (EFI), sponsored by Lyric Pharmaceuticals. Started Oct 2016; status: completed.
02
Drugs
ulimorelin
03
Conditions
enteral feeding intolerance (EFI)
Beyond the preview
Go deeper on NCT02784392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02784392.